首页|脑胶质瘤患者血清miR-186-5p、miR-942-5p表达及临床意义

脑胶质瘤患者血清miR-186-5p、miR-942-5p表达及临床意义

扫码查看
目的 探讨脑胶质瘤患者血清miR-186-5p和miR-942-5p表达及临床意义.方法 选取2019年10月至2021年12月在该院接受治疗的98例脑胶质瘤患者作为观察组,以及同期在该院体检的101例健康者作为对照组.采用荧光定量PCR(qPCR)法检测血清miR-186-5p和miR-942-5p的表达水平,多因素Cox回归分析脑胶质瘤患者预后的影响因素,受试者工作特征(ROC)曲线及曲线下面积(AUC)分析血清miR-186-5p、miR-942-5p对脑胶质瘤的诊断价值,Kaplan-Meier生存曲线分析血清miR-186-5p、miR-942-5p表达与患者预后的关系.结果 观察组血清中miR-186-5p表达水平低于对照组(P<0.05),miR-942-5p表达水平高于对照组(P<0.05);血清miR-186-5p、miR-942-5p单独及联合诊断脑胶质瘤的AUC分别为0.735、0.809、0.895;不同术前Karnofsky功能状态(KPS)评分、世界卫生组织(WHO)分级、局部浸润患者血清miR-186-5p低表达、miR-942-5p高表达比例差异有统计学意义(P<0.05);miR-186-5p高表达患者2年生存率高于miR-186-5p低表达患者(x2=6.455,P=0.011);miR-942-5p高表达患者2年生存率低于miR-942-5p低表达患者(x2=9.858,P=0.002);miR-186-5p是脑胶质瘤患者死亡的保护因素(P<0.05),miR-942-5p是危险因素(P<0.05).结论 脑胶质瘤患者血清miR-186-5p表达水平降低、miR-942-5p表达水平升高,二者对脑胶质瘤的发生具有一定的诊断价值.
Expression levels of serum miR-186-5p and miR-942-5p in patients with glioma and their clinical significance
Objective To investigate the expression levels of serum miR-186-5p and miR-942-5p in patients with glioma and their clinical significance.Methods A total of 98 patients with glioma who were treated in this hospital from October 2019 to December 2021 were selected as the monitored group,and 101 healthy indi-viduals who underwent physical examinations a the same time were selected as the control group.Quantitative fluorescent PCR(qPCR)method was applied to detect the expression levels of miR-186-5p and miR-942-5p in serum,and multivariate COX regression was applied to analyze the prognostic factors of glioma patients.Re-ceiver operating characteristic(ROC)curve and area under curve(AUC)were used to analyze the diagnostic value of serum miR-186-5p and miR-942-5p in glioma.Kaplan-Meier survival curve was used to analyze the re-lationship between serum miR-186-5p and miR-942-5p expression and prognosis of patients.Results The ex-pression level of serum miR-186-5p in monitored group was lower than that in the control group(P<0.05),and the expression level of miR-942-5p was higher than that in the control group(P<0.05).The AUC of ser-um miR-186-5p and miR-942-5p in the diagnosis of glioma alone and in combination were 0.735,0.809 and 0.895,respectively.There were significant differences in the proportion of low miR-186-5p expression and high miR-942-5p expression in serum of patients with different preoperative Karnofsky performance status(KPS)scores,World Health Organization(WHO)grades and local infiltration(P<0.05).The 2-year surviv-al rate of patients with high expression of miR-186-5p was higher than that of patients with low expression of miR-186-5p(x2=6.455,P=0.011).The 2-year survival rate of patients with high miR-942-5p expression was lower than that of patients with low miR-942-5p expression(x2=9.858,P=0.002).miR-186-5p was a protective factor for mortality in glioma patients(P<0.05),while miR-942-5p was a risk factor(P<0.05).Conclusion Serum miR-186-5p expression level decreases and miR-942-5p expression level increases in glioma patients,both of which have certain diagnostic value for the occurrence of glioma.

gliomamiR-186-5pmiR-942-5pprognosis

李文生、招春飞、姚杰钦、许成杰、肖健齐、蒋海平、张春雨、龙霄翱

展开 >

广东医科大学附属医院神经外科,广东湛江 524000

广东医科大学附属医院老年病区,广东湛江 524000

脑胶质瘤 miR-186-5p miR-942-5p 预后

2025

国际检验医学杂志
重庆市卫生信息中心

国际检验医学杂志

影响因子:1.013
ISSN:1673-4130
年,卷(期):2025.46(1)